Insider Stock Trading History of Young Robert C


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Young Robert C since year 2005. The trader's CIK number is 1205317. At the time of this reporting, Young Robert C is the Director of Aveo Pharmaceuticals Inc . (stock ticker symbol AVEO). See this page for all insider trading activities at Aveo Pharmaceuticals Inc .

Note that in the past YOUNG ROBERT C also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Young Robert C since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-02-19 AVEO Aveo Pharmaceuticals Inc Buy 990 6.60 6,533
2012-12-13 AVEO Aveo Pharmaceuticals Inc Buy 2,371 6.78 16,068
2012-12-03 AVEO Aveo Pharmaceuticals Inc Buy 1,250 6.41 8,012
2012-08-08 AVEO Aveo Pharmaceuticals Inc Buy 1,000 8.63 8,630
2011-08-30 WST West Pharmaceutical Services Inc Option Ex 3,468 19.36 67,157
2011-08-30 WST West Pharmaceutical Services Inc Sale 2,354 40.03 94,225
2011-08-18 AVEO Aveo Pharmaceuticals Inc Option Ex 6,500 7.44 48,360
2011-08-18 AVEO Aveo Pharmaceuticals Inc Sale 4,361 15.76 68,746
2010-07-23 HGSI Human Genome Sciences Inc Option Ex 2,830 2.09 5,914
2008-11-12 WST West Pharmaceutical Services Inc Option Ex 1,000 19.36 19,365
2007-08-09 WST West Pharmaceutical Services Inc Option Ex 1,932 19.36 37,413
2006-12-11 HGSI Human Genome Sciences Inc Option Ex 1,000 8.68 8,680
2006-08-10 WST West Pharmaceutical Services Inc Option Ex 1,500 11.60 17,407
2006-08-10 WST West Pharmaceutical Services Inc Option Ex 1,500 11.60 17,407
2006-08-07 WST West Pharmaceutical Services Inc Option Ex 500 11.60 5,802
2006-08-07 WST West Pharmaceutical Services Inc Sale 500 37.04 18,518
2006-05-19 HGSI Human Genome Sciences Inc Option Ex 1,000 8.68 8,680
2006-05-19 HGSI Human Genome Sciences Inc Option Ex 1,000 8.68 8,680
2006-01-05 HGSI Human Genome Sciences Inc Option Ex 1,000 8.68 8,680

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Young Robert C (Director of Aveo Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.